TickerHumHealth Care · covered US companies
Drug Manufacturers—General stocks, compared by the numbers
Explore valuation, revenue growth, operating margins and research scores side by side. Each metric is ranked separately—this is context, not a “best stock” list.
9 of 9 covered companies loaded.
| Company | Price | P/E ↓ | Revenue growth ↑ | Operating margin ↑ | Research score ↑ |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $294.45 | #6 50.7x | #2 10.7% | #2 32.2% | #4 63/100 |
| Amgen Inc. (AMGN) | $467.06 | #2 27.1x | #3 8.2% | #1 32.4% | #3 68/100 |
| Biogen Inc. (BIIB) | $250.48 | #7 108.4x | #8 2.3% | — | #6 53/100 |
| Bristol-Myers Squibb Company (BMY) | $62.32 | #1 13.8x | #7 4.2% | — | #2 69/100 |
| Gilead Sciences, Inc. (GILD) | $167.95 | — | #5 6.5% | #3 -7.6% | #9 45/100 |
| Johnson & Johnson (JNJ) | $283.52 | #4 43.1x | #4 7.8% | — | #5 60/100 |
| Eli Lilly and Company (LLY) | $1,427.28 | #5 46.3x | #1 45.5% | — | #1 70/100 |
| Merck & Co., Inc. (MRK) | $146.95 | #8 148.4x | #6 4.9% | — | #8 50/100 |
| Pfizer Inc. (PFE) | $28.83 | #3 41.2x | #9 1.3% | — | #7 51/100 |
Ranks compare only covered companies in this catalogue industry. Lower positive P/E ranks better; higher revenue growth, operating margin and research score rank better. Ties share a rank and missing values are excluded.